Latest Breaking News On - Joyce allaire - Page 14 : comparemela.com

Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLauren walkerEdwin tuckerAlex grayJoyce allaireJasper therapeutics incAmerican academy of allergyAnnual meetingKit mouseWendy pangSenior vice presidentChief medicalAbstract titlePrevents passive systemic anaphylaxisMice expressing chimeric humanMast cell depletion poster number

Jasper Therapeutics Presents Data From Preclinical Briquilimab Studies At The American Academy Of Allergy, Asthma, And Immunology (AAAAI) Annual Meeti

Jasper Therapeutics Presents Data From Preclinical Briquilimab Studies At The American Academy Of Allergy, Asthma, And Immunology (AAAAI) Annual Meeti
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesJoyce allaireLauren walkerEdwin tuckerAlex grayAmerican academy of allergyJasper therapeutics incAnnual meetingWendy pangSenior vice presidentTranslational medicineChief medical officerPrevents passive systemic anaphylaxisMice expressing chimeric humanMast cell depletionTherapeutic trials

Ocular Therapeutix™ Announces Board of Directors and Leadership Updates

Ocular Therapeutix™ Announces Board of Directors and Leadership Updates
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Drexel universityUnited statesColumbia universityNew yorkCity ofUnited kingdomCzech republicBoston universityBorough of bedfordSanjay nayakPravinu dugelPeter jarrettAllergan abbvieJoyce allaireAntony mattessichPeterk kaiser

Ocular Therapeutix Reports Inducement Grants Under Nasdaq

BEDFORD, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing.

Donald notmanPravinu dugelJoyce allaireSanjay nayakCompensation committee of ocularOcular therapeutix incExecutive chairmanChief strategy officerCompensation committeeStock incentive planNasdaq listing ruleNasdaq global marketStock incentiveOcular therapeutixNasdaq oculOcular therapeutix

Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Chairman and Chief Strategy Officer

Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Chairman and Chief Strategy Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Pravinu dugelSanjay nayakDonald notmanJoyce allaireCompensation committee of ocularOcular therapeutix incNewly appointed executive chairmanChief strategyExecutive chairmanChief strategy officerCompensation committeeStock incentive planNasdaq listing ruleNasdaq global marketStock incentiveOcular therapeutix